MD Medical Group plans IPO in London in Oct

By Admin
Russian healthcare organization MD Medical Group aims to come up with an IPO and list in London in October, the news reports said. The company hopes to...

Russian healthcare organization MD Medical Group aims to come up with an IPO and list in London in October, the news reports said. The company hopes to raise about $150 million despite a number of cancelled IPOs.

MD Medical Group is likely to announce this week its aim to sell global depositary receipts representing 30% of the company’s shares in London.

To manage the IPO, JP Morgan and Deutsche Bank have been considered. The global healthcare company plans to use the proceeds to fund its current capital spending program that includes building in the Russian city of Ufa as also for general corporate purposes.

Elena Mladova, Chief Executive said, “Funds raised from the offering will help us to expand and to take advantage of the unfulfilled demand in Russia for high-quality medical devices.”

The global heathcare company will benefit from operating in defensive sector and an economically robust emerging market.  MD Medical Group runs a private maternity hospital in Moscow. It has also acquired eight outpatient clinics in 2011, almost 59% year-on-year to 851 m roubles ($28 m) in the first six months of 2012.

According to reports, the biggest test of the IPO market this year, is likely to be Direct Line, the insurance subsidiary of Royal Bank of Scotland.

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare